Camp Lejeune cancer lawsuit

Those Already Receiving VA Benefits Under the Camp Lejeune Families Act Of 2012 Can Expect The Fastest Camp Lejeune Justice Act Payout

Claimants who file a complete and accurate claim under the Elective Option can expect an offer within 60 days

Friday, March 29, 2024 - The time frame during which families, veterans, and others may submit administrative claims and lawsuits under the Camp Lejeune Justice Act, a landmark piece of legislation passed in 2022, offering lump-sum damages for injuries related to the base's tainted water supply between the 1950s to 1980s, is rapidly drawing to an end. Those who were medically impacted by Camp Lejeune's tainted water have until August 10 to bring legal action against the US government. If you or a loved one is a veteran service member having spent time at Camp Lejeune, a civilian employee there, or another person who was repeatedly exposed to the water there at any time between 1953 and 1987 and is currently receiving benefits under the Camp Lejeune Families Act of 2012, you must strongly consider filing for the Elective Option and accepting the predetermined lump sum. The elective option is the way for someone who is water contamination-injured to continue to receive their VA CLFA benefits and also get a lump-sum Camp Lejeune Justice Act Payout. According to Military.com, " The Camp Lejeune Families Act of 2012 first established eligibility for toxic-water benefits from the VA. Veterans with illnesses presumed to be connected to the water contamination qualify for disability benefits and/or health care from the VA, and family members may also qualify for health care. Receiving a (CLJA) settlement won't affect any benefits a veteran or family member might qualify for, but receiving benefits might affect the final amount awarded in a claim or lawsuit." One should also take into consideration that Camp Lejeune attorney fees can be as high as 25% based on the total award.

The military anticipates being able to move Elective Option claims to the front of the line and process them expeditiously since one's medical eligibility has already been established and the potential for a fraudulent claim eliminated. Military.com advised readers recently, " Claimants who file a complete and accurate claim under the EO can expect payment within 60 days, according to the Department of the Navy." Most of the presumed types of cancer overlap the CLFA and the CLJA. Be aware, however, that one's Elective Option amount may be reduced to take into consideration having already received some compensation. For Tier One in the Elective Option, one would have been medically diagnosed as having one or more of the following types of disease: Kidney cancer, Liver cancer, non-Hodgkin lymphoma, Leukemia, or Bladder cancer. Maximum settlements and the time required to have been spent on the base under Tier One are 30-364 days of exposure: $150,000, 1-5 years of exposure: $300,000, and more than 5 years of exposure: $450,000. Qualifying Camp Lejeune water injuries under the Second Tier are Multiple myeloma, Parkinson's disease, Kidney disease/end-stage renal disease, and Systemic sclerosis/systemic scleroderma, which could pay the following based on the term of exposure, 30-364 days of exposure: $100,000, 1-5 years of exposure: $250,000, More than 5 years of exposure: $400,000. Survivors of those who died from exposure to Camp Lejeune water will receive an additional $100,000 in all of the above instances.

Information provided by CampLejeuneJusticeActClaim.com, a website devoted to providing news about Camp Lejeune Justice Act Claim, including a free no-cost, no-obligation Camp Lejeune Justice Act Claim.

More Recent Camp Lejeune Water Lawsuit News:

View all Camp Lejeune Justice Act Claim News

No-Cost, No-Obligation Claim Review for Persons or Families of Persons Who Developed Cancer After Spending 30 Days or More at Camp Lejeune between 1953 and 1988

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.


Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.